ACADIA Pharmaceuticals Reports Strong Earnings and Growth Plans
PremiumCompany AnnouncementsACADIA Pharmaceuticals Reports Strong Earnings and Growth Plans
1M ago
Positive Outlook for ACADIA Pharmaceuticals Driven by Strong Daybue Sales and Promising Pipeline
Premium
Ratings
Positive Outlook for ACADIA Pharmaceuticals Driven by Strong Daybue Sales and Promising Pipeline
1M ago
Acadia Pharmaceuticals price target lowered to $37 from $39 at Citizens JMP
Premium
The Fly
Acadia Pharmaceuticals price target lowered to $37 from $39 at Citizens JMP
1M ago
ACADIA Pharmaceuticals: Strong Financial Performance and Growth Prospects Justify Buy Rating
PremiumRatingsACADIA Pharmaceuticals: Strong Financial Performance and Growth Prospects Justify Buy Rating
1M ago
Acadia Pharmaceuticals reports Q4 EPS 86c, consensus 22c
Premium
The Fly
Acadia Pharmaceuticals reports Q4 EPS 86c, consensus 22c
1M ago
Acadia Pharmaceuticals sees FY25 revenue $1.03B-$1.095B, consensus $1.05B
Premium
The Fly
Acadia Pharmaceuticals sees FY25 revenue $1.03B-$1.095B, consensus $1.05B
1M ago
Block upgraded, Bumble downgraded: Wall Street’s top analyst calls
PremiumThe FlyBlock upgraded, Bumble downgraded: Wall Street’s top analyst calls
3M ago
Guggenheim downgrades Acadia Pharmaceuticals to Neutral on lack of catalysts
Premium
The Fly
Guggenheim downgrades Acadia Pharmaceuticals to Neutral on lack of catalysts
3M ago
Acadia Pharmaceuticals downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Acadia Pharmaceuticals downgraded to Neutral from Buy at Guggenheim
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100